HER2 Support Group Forums - View Single Post

Lani · 05-27-2015, 04:48 PM

I don't go with the fear factor--in fact I think it would keep many many more from overtreatment and save money and healthy productive lives.

More patients are in fear if they don't know if the treatment they had worked
and if it was the right treatment.

If movies did not confuse lumbar punctures, bone marrow biopsies and being put on the rack in movies about Elizabethan England, things would be much better.

A 80 year old neighbor of mine with no diseases volunteered for $100 to get a bone marrow for a study and thought the discomfort a 4 out of 10 for about 2 seconds and then a 1 or 2 out of 10 soreness if she leaned the biopsy site back into a hard seat for 2-3 days(she weights about 90 lbs and has no "upholstery").

Anything that helps identify ONLY those that need the treatment, the best/least treatment for them cannot help to save money-- but pharma only wants to develop expensive drugs for a sufficiently large population or orphan drugs where unlimited profits and lengthy patent rights are ensured, it seems.

05-27-2015, 04:48 PM	#11
Lani Senior Member Join Date: Mar 2006 Posts: 4,778	Re: Brain mets but no systemic disease I don't go with the fear factor--in fact I think it would keep many many more from overtreatment and save money and healthy productive lives. More patients are in fear if they don't know if the treatment they had worked and if it was the right treatment. If movies did not confuse lumbar punctures, bone marrow biopsies and being put on the rack in movies about Elizabethan England, things would be much better. A 80 year old neighbor of mine with no diseases volunteered for $100 to get a bone marrow for a study and thought the discomfort a 4 out of 10 for about 2 seconds and then a 1 or 2 out of 10 soreness if she leaned the biopsy site back into a hard seat for 2-3 days(she weights about 90 lbs and has no "upholstery"). Anything that helps identify ONLY those that need the treatment, the best/least treatment for them cannot help to save money-- but pharma only wants to develop expensive drugs for a sufficiently large population or orphan drugs where unlimited profits and lengthy patent rights are ensured, it seems.